- Article
- Source: Campus Sanofi
- 23 Oct 2023
Preserving Brain Health | Part 2: Clinical Progression and Smouldering Disease - Prof. Gavin Giovannoni
Prescribing Information can be found through the links at the Product Carousel on the bottom of the page.
Speaker:
Professor Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath
Barts and the London School of Medicine and Dentistry, UK
Learning Objectives:
-
To understand that ‘inactive’ MS is rarely truly inactive
- To recognise that the Lublin classification of MS phenotypes may not fit the current understanding of the continuum of acute and chronic inflammatory process over the course of disease
- To identify that age-related processes compound MS progression by contributing to the loss of neural reserve.
Reflective learning guide and CPD certificate
.jpg)
Related Videos
22:45
AUBAGIO® (teriflunomide) Overview: Efficacy (Brain Health) and Real-World (Patient-Reported Outcomes, Adherence, Effectiveness) - Prof. Jiwon Oh
22:30
AUBAGIO® (teriflunomide): MoA and Safety - Prof. Patrick Vermersch
18:56
Preserving Brain Health | Part 1: Underlying Pathology of Chronic Smouldering MS - Prof. Gavin Giovannoni
24:53
Preserving Brain Health | Part 3: Advanced Imaging Techniques in Routine Clinical Practice - Prof. Jiwon Oh
22:45
AUBAGIO® (teriflunomide) Overview: Efficacy (Brain Health) and Real-World (Patient-Reported Outcomes, Adherence, Effectiveness) - Prof. Jiwon Oh
22:30
AUBAGIO® (teriflunomide): MoA and Safety - Prof. Patrick Vermersch
18:56
Preserving Brain Health | Part 1: Underlying Pathology of Chronic Smouldering MS - Prof. Gavin Giovannoni
24:53
Preserving Brain Health | Part 3: Advanced Imaging Techniques in Routine Clinical Practice - Prof. Jiwon Oh
Neurology Products
|
Prescribing Information GB MAT-XU-2200676 (v6.0) |
|
Prescribing Information GB MAT-XU-2200680 (v3.0) |
MAT-XU-2302955 (v1.0) Date of preparation: October 2023